4Pioro PJ. Loss of substance P and enkephalin immunoreactivity in the human substantiaigra after striato - pallidal infarction [J]. Brain Res, 1984,4(2):291.
8Motta P,Pons N,Pagliarusco S,et al.Casopitant:in vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4.Drug Metab Dispos,2011,39(3):363-372.
9Gan TJ,Gu J,Singla N,et al.Rolapitant for the Prevention of Postoperative Nausea and Vomiting:A Prospective,Double-Blinded,Placebo-Controlled Randomized Trial.Anesth Analg,2011,112(4):804-812.
10Hunt CM,Papay JI,Rich DS,et al.The evaluation of drug rechallenge:the casopitant Phase Ⅲ program.Regul Toxicol Pharmacol,2010,58(3):539-543.
